Article
Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients.
Stroke and vascular neurology - 21 Jun 2024
Liu Qingyuan, Guo Shuaiwei, Wang Nuochuan, Wang Kaiwen, Mo Shaohua, Li Xiong, Zhang Yanan, He Hongwei, Wang Shuo, Wu Jun
Abstract excerpt
BACKGROUND: Aspirin is widely used for preventing ischaemic events. About 20%-40% of patients have aspirin resistance (ASR), which prevents them from benefiting from aspirin medication. This study aimed to develop and validate a model based on single-nucleotide polymorphism (SNP) to distinguish ASR patients. METHODS: We included patients with spontaneous intracerebral haemorrhage and continuing antiplatelet...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
